Glaucocalyxin A
CAS No. 79498-31-0
Glaucocalyxin A ( —— )
Catalog No. M19111 CAS No. 79498-31-0
Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 90 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlaucocalyxin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.
-
DescriptionGlaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery. Glaucocalyxin A activates caspase-3, decreases BAD phosphorylation, and reduces the expression of X-linked inhibitor of apoptosis protein. Glaucocalyxin A inhibits Akt phosphorylation, suppresses proliferation, and promotes apoptosis in a dose-dependent manner, but not in normal glial cells. Glaucocalyxin A inhibits collagen-stimulated tyrosine phosphorylation of Syk, LAT, and phospholipase Cγ2, the signaling events in collagen receptor GPⅥ pathway. Glaucocalyxin A could potentially be developed as an antiplatelet and antithrombotic agent, can inhibit platelet p-selectin secretion and integrin activation by convulxin, is a GPVI selective ligand.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorCaspase-3;Akt
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number79498-31-0
-
Formula Weight332.44
-
Molecular FormulaC20H28O4
-
Purity98%
-
Solubility——
-
SMILESCC1(C2CC(C34C(C2(CCC1=O)C)CCC(C3O)C(=C)C4=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PD173074
PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.
-
WZ4002
WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM.
-
UNC0631
UNC0631 is a effectvie histone methyltransferase G9a inhibitor (IC50=4 nM).